发明名称 N-SUBSTITUTED 8-[(2,6-DIFLUOROBENZYL)OXY]-2,6-DIMETHYLIMIDAZO[1,2-A]PYRAZIN-3-CARBOXAMIDE DERIVATIVES AS STIMULATORS OF SOLUBLE GUANYLATE CYLASE (SGC) FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
摘要 The invention relates to n-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6-dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (sGC) for the treatment of cardiovascular diseases, such as for example heart insufficiency, angina pectoris, hypertension, pulmonary hypertension, ischaemia, vascular diseases, renal insufficiency, thromboembolic diseases, fibrotic diseases, arteriosclerosis, dementia diseases and erectile dysfunction.
申请公布号 WO2016124564(A1) 申请公布日期 2016.08.11
申请号 WO2016EP52123 申请日期 2016.02.02
申请人 BAYER PHARMA AKTIENGESELLSCHAFT 发明人 VAKALOPOULOS, ALEXANDROS;BROCKSCHNIEDER, DAMIAN;WUNDER, FRANK;STASCH, JOHANNES-PETER;MARQUARDT, TOBIAS;DIETZ, LISA;LI, MIN JIAN VOLKHART
分类号 C07D487/04;A61K31/4985;A61P9/00;A61P9/10;A61P9/12;A61P15/10;A61P25/28 主分类号 C07D487/04
代理机构 代理人
主权项
地址